State-of-the-art Tools for Computational Site of Metabolism Predictions: Comparative Analysis, Mechanistical Insights, and Future Applications

REFERENCES

• Afzelius L., Masimirembwa C. M., Karlen A., Andersson T. B., Zamora I. Discriminant and quantitative PLS analysis of competitive CYP2C9 inhibitors versus non-inhibitors using alignment independent GRIND descriptors. J. Comput. Aided Mol. Des. 2002; 16(7)443–458
   PubMed Web of Science ®Google Scholar
• Afzelius L., Zamora I., Masimirembwa C. M., Karlen A., Andersson T. B., Mecucci S., Baroni M., Cruciani G. Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors. J. Med. Chem. 2004; 47(4)907–914
   PubMed Web of Science ®Google Scholar
• Afzelius L., Zamora I., Ridderstrom M., Andersson T. B., Karlen A., Masimirembwa C. M. Competitive CYP2C9 inhibitors: enzyme inhibition studies, protein homology modeling, and three-dimensional quantitative structure-activity relationship analysis. Mol. Pharmacol. 2001; 59(4)909–919
   PubMed Web of Science ®Google Scholar
• Bell-Parikh L. C., Guengerich F. P. Kinetics of cytochrome P450 2E1-catalyzed oxidation of ethanol to acetic acid via acetaldehyde. J. Biol. Chem. 1999; 274(34)23833–23840
   PubMed Web of Science ®Google Scholar
• Boyer S., Hasselgren-Arnby C., Carlsson L., Smith J., Glen R. SPORCalc: A method for fingerprint-based probabilistic sScoring of metabolically labile sites. J. Chem. Inf. Comput. Sci. submitted 2006
   Google Scholar
• Boyer S., Zamora I. New methods in predictive metabolism. J. Comput. Aided Mol. Des. 2002; 16(5/6)403–413
   PubMed Web of Science ®Google Scholar
• Case, D. A., Pearlman, D. A., Caldwell, J. W., Cheatham III, T. E., Wang, J., Ross, W. S., Simmerling, C. L., Darden, T. A., Merz, K. M., Stanton, R. V., Cheng, A. L., Vincent, J. J., Crow-ley, M., Tsui, V., Gohlke, H., Radmer, R. J., Duan, Y., Pitera, J., Massova, I., Seibel, G. L., Singh, U. C., Weiner, P. K., Kollman, P. A. (2002). Antechamber/Amber7. University of California, San Francisco.
   Google Scholar
• Cruciani G., Carosati E., De Boeck B., Ethirajulu K., Mackie C., Howe T., Vianello R. MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J. Med. Chem. 2005; 48(22)6970–6979
   PubMed Web of Science ®Google Scholar
• de Graaf C., Oostenbrink C., Keizers P., van der Wijst T., Jongejan A., Vermeulen N. P. Catalytic Site Prediction and Virtual Screening of Cytochrome P450 2D6 Substrates by Consideration of Water and Rescoring in Automated Docking. J. Med. Chem. 2006; 49: 2417–2430
   PubMed Web of Science ®Google Scholar
• de Graaf C., Vermeulen N. P., Feenstra K. A. Cytochrome p450 in silico: an integrative modeling approach. J. Med. Chem. 2005; 48(8)2725–2755
   PubMed Web of Science ®Google Scholar
• de Groot M. J., Ackland M. J., Horne V. A., Alex A. A., Jones B. C. A Novel Approach to Predicting P450 Mediated Drug Metabolism. CYP2D6 catalyzed N-dealkylation Reactions and Qualitative Metabolite Predictions Using a Combined Protein and Pharmacophore Model for CYP2D6. J. Med. Chem. 1999; 42: 4062–4070
   PubMed Web of Science ®Google Scholar
• de Groot M. J., Ackland M. J., Horne V. A., Alex A. A., Jones B. C. Novel approach to predicting P450-mediated drug metabolism: development of a combined protein and pharmacophore model for CYP2D6. Journal of Medicinal Chemistry 1999; 42(9)1515–1524
   PubMed Web of Science ®Google Scholar
• de Groot M. J., Alex A. A., Jones B. C. Development of a combined protein and pharmacophore model for cytochrome P450 2C9. J. Med. Chem. 2002; 45(10)1983–1993
   PubMed Web of Science ®Google Scholar
• Ekins S., Bravi G., Binkley S., Gillespie J. S., Ring B. J., Wikel J. H., Wrighton S. A. Three and four dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2D6 inhibitors. Pharmacogenetics 1999; 9(4)477–489
   PubMedGoogle Scholar
• Ekins S., Bravi G., Binkley S., Gillespie J. S., Ring B. J., Wikel J. H., Wrighton S. A. Three- and four-dimensional-quantitative structure activity relationship (3D/4D-QSAR) analyses of CYP2C9 inhibitors. Drug Metab. Dispos. 2000; 28(8)994–1002
   PubMed Web of Science ®Google Scholar
• Ekroos M., Sjogren T. Structural basis for ligand promiscuity in cytochrome P450 3A4. Proc. Natl. Acad. Sci. U.S.A 2006; 103(37)13682–13687
   PubMed Web of Science ®Google Scholar
• Friesner R. A., Banks J. L., Murphy R. B., Halgren T. A., Klicic J. J., Mainz D. T., Repasky M. P., Knoll E. H., Shelly M., Perry J. K., Shaw D. E., Francis P., Shenkin P. S. Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy. J. Med. Chem. 2004; 47: 1739–1749
   PubMed Web of Science ®Google Scholar
• Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Montgomery, J. J. A., Vreven, T., Kudin, K. N., Burant, J. C., Millam, J. M., Iyengar, S. S., Tomasi, J., B­arone, V., Mennucci, B., Cossi, M., Scalmani, G., Rega, N., Petersson, G. A., Nakatsuji, H., Hada, M., Ehara, M., Toyota, K., Fukuda, R., Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Klene, M., Li, X., Knox, J. E., Hratchian, H. P., Cross, J. B., Adamo, C., Jaramillo, J., Gomperts, R., Stratmann, R. E., Yazyev, O., Austin, A. J., Cammi, R., Pomelli, C., Ochterski, J. W., Ayala, P. Y., Morokuma, K., Voth, G. A., Salvador, P., Dannenberg, J. J., Zakrzewski, V. G., Dapprich, S., Daniels, A. D., Strain, M. C., Farkas, O., Malick, D. K., Rabuck, A. D., Raghavachari, K., Foresman, J. B., Ortiz, J. V., Cui, Q., Baboul, A. G., Clifford, S., Cioslowski, J., Stefanov, B. B., Liu, G., Liashenko, A., Piskorz, P., Komaromi, I., Martin, R. L., Fox, D. J., Keith, T., A­l-Laham, M. A., Peng, C. Y., Nanayakkara, A., Challacombe, M., Gill, P. M. W., Johnson, B., Chen, W., Wong, M. W., Gonzalez, C., Pople, J. A. (2003). Gaussian 03 Revision B.05. Pittsburgh PA: Gaussian, Inc.
   Google Scholar
• Gasteiger J., Rudolph C., Sadowski J. Automatic generation of 3D atomic coordinates for organic molecules. Tetrahedron Comput. Methodol. 1990; 3(6:3)537–547
   Google Scholar
• Goodword P. J. A computational procedure for determining energitically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985; 28: 849–857
   PubMed Web of Science ®Google Scholar
• Guengerich F. P. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 2001; 14(6)611–650
   PubMed Web of Science ®Google Scholar
• Isin E. M., Guengerich F. P. Kinetics and thermodynamics of ligand binding by cytochrome P450 3A4. J. Biol. Chem. 2006; 281(14)9127–9136
   PubMed Web of Science ®Google Scholar
• Jones J. P., He M., Trager W. F., Rettie A. E. Three-dimensional quantitative structure-activity relationship for inhibitors of cytochrome P4502C9. Drug Metabolism & Disposition 1996; 24(1)1–6
   PubMed Web of Science ®Google Scholar
• Kirton S. B., Kemp C. A., Tomkinson N. P., St-Gallay S., Sutcliffe M. J. Impact of incorporating the 2C5 crystal structure into comparative models of cytochrome P450 2D6. Proteins 2002; 49(2)216–231
   PubMed Web of Science ®Google Scholar
• Mancy A., Broto P., Dijols S., Dansette P. M., Mansuy D. The substrate binding site of human liver cytochrome P450 2C9: an approach using designed tienilic acid derivatives and molecular modeling. Biochemistry 1995; 34(33)10365–10375
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The Carbon Monoxide-binding Pigment of Liver Microsomes. II. Evidence for its hemoprotein nature. J. Biol. Chem. 1964; 239: 2379–2385
   PubMed Web of Science ®Google Scholar
• Pompon D., Coon M. J. On the mechanism of action of cytochrome P450: oxidation and reduction of the ferrous dioxygen complex of liver microsomal cytochrome P450 by cytochrome b5. J. Biol. Chem. 1984; 259: 15377–15385
   PubMed Web of Science ®Google Scholar
• Poulos T. L., Finzel B. C., Howard A. J. High-resolution crystal structure of cytochrome P450cam. J. Mol. Biol. 1987; 195(3)687–700
   PubMed Web of Science ®Google Scholar
• Richards, F. M. (2002). DMS. The Regents of the University of California: CGL.
   Google Scholar
• Rowland P., Blaney F. E., Smyth M. G., Jones J. J., Leydon V. R., Oxbrow A. K., Lewis C. J., Tennant M. G., Modi S., Eggleston D. S., Chenery R. J., Bridges A. M. Crystal structure of human cytochrome P450 2D6. J. Biol. Chem. 2006; 281(11)7614–7622
   PubMed Web of Science ®Google Scholar
• Schlichting I., Berendzen J., Chu K., Stock A. M., Maves S. A., Benson D. E., Sweet R. M., Ringe D., Petsko G. A., Sligar S. G. The catalytic pathway of cytochrome p450cam at atomic resolution. Science 2000; 287(5458)1615–1622
   PubMed Web of Science ®Google Scholar
• Schoch G. A., Yano J. K., Wester M. R., Griffin K. J., Stout C. D., Johnson E. F. Structure of human microsomal cytochrome P450 2C8. Evidence for a peripheral fatty acid binding site. J. Biol. Chem. 2004; 279(10)9497–9503
   PubMed Web of Science ®Google Scholar
• Shaik S., Cohen S., de Visser S. P., Sharma P. K., Kumar D., Kozuch S., Ogliaro F., Danovich D. The “Rebound Controversy”: An overview and theoretical modeling of the rebound step in C-H hydroxylation by cytochrome P450. Eur. J. Inorg. Chem. 2004; 2004(2)207–226
   Web of Science ®Google Scholar
• Singh S. B., Shen L. Q., Walker M. J., Sheridan R. P. A model for predicting likely sites of CYP3A4-mediated metabolism on drug-like molecules. Journal of Medicinal Chemistry 2003; 46(8)1330–1336
   PubMed Web of Science ®Google Scholar
• Venhorst J., ter Laak A. M., Commandeur J. N., Funae Y., Hiroi T., Vermeulen N. P. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities. J. Med. Chem. 2003; 46(1)74–86
   PubMed Web of Science ®Google Scholar
• Wester M. R., Johnson E. F., Marques-Soares C., Dansette P. M., Mansuy D., Stout C. D. Structure of a substrate complex of mammalian cytochrome P450 2C5 at 2.3 Å resolution: evidence for multiple substrate binding modes. Biochemistry 2003; 42(21)6370–6379
   PubMed Web of Science ®Google Scholar
• Wester M. R., Johnson E. F., Marques-Soares C., Dijols S., Dansette P. M., Mansuy D., Stout C. D. Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 Å resolution: evidence for an induced fit model of substrate binding. Biochemistry 2003; 42(31)9335–9345
   PubMed Web of Science ®Google Scholar
• Wester M. R., Yano J. K., Schoch G. A., Yang C., Griffin K. J., Stout C. D., Johnson E. F. The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-Å resolution. J. Biol. Chem. 2004; 279(34)35630–35637
   PubMed Web of Science ®Google Scholar
• Williams P. A., Cosme J., Sridhar V., Johnson E. F., McRee D. E. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol. Cell 2000a; 5(1)121–131
   PubMed Web of Science ®Google Scholar
• Williams P. A., Cosme J., Sridhar V., Johnson E. F., McRee D. E. Microsomal cytochrome P450 2C5: comparison to microbial P450s and unique features. Journal of Inorganic Biochemistry 2000b; 81(3)183–190
   PubMed Web of Science ®Google Scholar
• Williams P. A., Cosme J., Ward A., Angove H. C., Matak Vinkovic D., Jhoti H. Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 2003; 424(6947)464–468
   PubMed Web of Science ®Google Scholar
• Williams P. A., Cosme J., Vinkovic D. M., Ward A., Angove H. C., Day P. J., Vonrhein C., Tickle I. J., Jhoti H. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science 2004; 305(5684)683–686
   PubMed Web of Science ®Google Scholar
• Yano J. K., Hsu M. H., Griffin K. J., Stout C. D., Johnson E. F. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nature Structural & Molecular Biology 2005; 12(9)822–823
   PubMed Web of Science ®Google Scholar
• Yano J. K., Wester M. R., Schoch G. A., Griffin K. J., Stout C. D., Johnson E. F. The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-Å resolution. J. Biol. Chem. 2004; 279(37)38091–38094
   PubMed Web of Science ®Google Scholar
• Zamora I., Afzelius L., Cruciani G. Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. J. Med. Chem. 2003; 46(12)2313–2324
   PubMed Web of Science ®Google Scholar